Comparing Ampyra vs Aubagio
Ampyra | Aubagio |
|
---|
Ampyra (dalfampridine) | Aubagio (teriflunomide) |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Multiple Sclerosis. Ampyra may also be used for purposes not listed in this medication guide. |
Prescription only
Aubagio is a selective immunosuppressant that may be used in the treatment of multiple sclerosis. It interacts with many other medications and carries a boxed warning about the risk of liver toxicity... View more |
Related suggestions Popular comparisons
|
|||||||||||||||
More about Ampyra (dalfampridine) | More about Aubagio (teriflunomide) | ||||||||||||||||
Generic Status | |||||||||||||||||
Ratings & Reviews | |||||||||||||||||
Ampyra has an average rating of 8.0 out of 10 from a total of 76 ratings on Drugs.com. 73% of reviewers reported a positive effect, while 13% reported a negative effect. |
Aubagio has an average rating of 5.3 out of 10 from a total of 82 ratings on Drugs.com. 35% of reviewers reported a positive effect, while 39% reported a negative effect. |
||||||||||||||||
Drug Class | |||||||||||||||||
Side Effects | |||||||||||||||||
Common side effects include:
See also: Ampyra side effects in more detail. |
Common side effects include:
See also: Aubagio side effects in more detail. |
||||||||||||||||
Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Ampyra prices and generic prices |
View all Aubagio prices and generic prices |
||||||||||||||||
Dosage Form(s) Available | |||||||||||||||||
|
|
||||||||||||||||
Brand Names | |||||||||||||||||
N/A |
N/A |
||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | |||||||||||||||||
6.5 hours |
456 hours |
||||||||||||||||
CSA Schedule ** View glossary of terms | |||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | |||||||||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | |||||||||||||||||
A total of 48 drugs are known to interact with Ampyra:
|
A total of 675 drugs are known to interact with Aubagio:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||||||||||
Disease Interactions | |||||||||||||||||
First Approval Date | |||||||||||||||||
January 22, 2010 |
September 12, 2012 |
||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | |||||||||||||||||
N/A |
N/A |
||||||||||||||||
More Information | |||||||||||||||||
Patient resources | |||||||||||||||||
Professional Resources | |||||||||||||||||
Related Treatment Guide | |||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.